Selected miRNAs in oropharyngeal squamous cell carcinoma (OPSCC) with HPV and EBV coinfection
References
- Jiang R, Ekshyyan O, Moore-Medlin T, Rong X, Nathan S, Gu X, et al. Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis. J Oral Pathol Med. 2015;44(1):28-36.
- Syrjänen S. Oral manifestations of human papillomavirus infections. Eur J Oral Sci. 2018;126(S1):49-66.
- Carpén T, Syrjänen S, Jouhi L, Randen-Brady R, Haglund C, Mäkitie A, et al. Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact. Cancer Immunol Immunother. 2020;69(8):1615-26.
- Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60-72.
- Alibek K, Kakpenova A, Baiken Y. Role of infectious agents in the carcinogenesis of brain and head and neck cancers. Infect Agent Cancer. 2013;8(1):7.
- Hillbertz NS, Hirsch JM, Jalouli J, Jalouli MM, Sand L. Viral and molecular aspects of oral cancer. Anticancer Res. 2012;32(10):4201-12.
- Al Moustafa AE, Chen D, Ghabreau L, Akil N. Association between human papillomavirus and Epstein-Barr virus infections in human oral carcinogenesis. Med Hypotheses. 2009;73(2):184-6.
- Makielski KR, Lee D, Lorenz LD, Nawandar DM, Chiu YF, Kenney SC, et al. Human papillomavirus promotes Epstein-Barr virus maintenance and lytic reactivation in immortalized oral keratinocytes. Virology. 2016;495:52-62.
- Drop B, Strycharz-Dudziak M, Kliszczewska E, Polz-Dacewicz M. Coinfection with Epstein-Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in laryngeal, oropharyngeal and oral cavity cancer. Int J Mol Sci. 2017;18(12):E2752.
- Shi J, Bao X, Liu Z, Zhang Z, Chen W, Xu Q. Serum miR-626 and miR-5100 are promising prognosis predictors for oral squamous cell carcinoma. Theranostics. 2019;9(4):920-31.
- Diez-Fraile A, De Ceulaer J, Derpoorter C, Spaas C, De Backer T, Lamoral P, et al. Tracking the molecular fingerprint of head and neck cancer for recurrence detection in liquid biopsies. Int J Mol Sci. 2022;23(5):2403.
- Dumache R. Early diagnosis of oral squamous cell carcinoma by salivary microRNAs. Clin Lab. 2017;63(11):1771-6.
- Schneider A, Victoria B, Lopez YN, Suchorska W, Barczak W, Sobecka A, et al. Tissue and serum microRNA profile of oral squamous cell carcinoma patients. Sci Rep. 2018;8(1):675.
- Manikandan M, Deva Magendhra Rao AK, Arunkumar G, Manickavasagam M, Rajkumar KS, Rajaraman R, et al. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism. Mol Cancer. 2016;15(1):28.
- Romano G, Veneziano D, Acunzo M, Croce CM. Small non-coding RNA and cancer. Carcinogenesis. 2017;38(5):485-91.
- Cameron JE, Fewell C, Yin Q, McBride J, Wang X, Lin Z, et al. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology. 2008;382(2):257-66.
- Wang Z, Qiao Q, Chen M, Li X, Wang Z, Liu C, et al. miR-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2. FEBS Letters. 2014;588(6):915-21.
- Zhang M, Xiong F, Zhang S, Guo W, He Y. Crucial roles of miR-625 in human cancer. Front Med (Lausanne). 2022;9:845094.
- Lu Z, He Q, Liang J, Li W, Su Q, Chen Z, et al. miR-31-5p is a potential circulating biomarker and therapeutic target for oral cancer. Mol Ther Nucleic Acids. 2019;16:471-80.
- Yi SJ, Liu P, Chen BL, Ou-Yang L, Xiong WM, Su JP. Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma. Neoplasma. 2019;66(5):825-9.
- Wang T, Liu X, Tian Q, Liang T, Chang P. Increasing expression of miR-5100 in non-small-cell lung cancer and correlation with prognosis. Eur Rev Med Pharmacol Sci. 2017;21(16):3592-7.
- WHO classification of tumours series. In: Head and Neck Tumours, 5th ed. International Agency for Research on Cancer: Lyon, France. 2022;9.
- Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual, 8th ed. Springer: New York, NY, USA; 2017.
- Kobayashi K, Hisamatsu K, Suzui N, Hara A, Tomita H, Miyazaki T. A review of HPV-related head and neck cancer. J Clin Med. 2018;7(9):241.
- Roden RBS, Stern PL. Opportunities and challenges for human papillomavirus vaccination in cancer. Nat Rev Cancer. 2018;18(4):240-54.
- Vedham V, Divi RL, Starks VL, Verma M. Multiple infections and cancer: implications in epidemiology. Technol Cancer Res Treat. 2014;13(2):177-94.
- Guidry JT, Scott RS. The interaction between human papillomavirus and other viruses. Virus Res. 2017;231:139-47.
- Elmusrati A, Wang J, Wang CY. Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma. Int J Oral Sci. 2021;13(1):1-11.
- Peltanova B, Raudenska M, Masarik M. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol Cancer. 2019;18(1):63.
- Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423-37.
- Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M. The pathogenesis of Epstein-Barr virus persistent infection. Curr Opin Virol. 2013;3(3):227-32.
- Zhu Q, Wang Z, Hu Y, Li J, Li X, Zhou L, et al. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep. 2012;27(5):1660-8.
- Lamperska KM, Kozlowski P, Kolenda T, Teresiak A, Blizniak R, Przybyla W, et al. Unpredictable changes of selected miRNA in expression profile of HNSCC. Cancer Biomarkers. 2016;16(1):55-64.
- Yan ZY, Luo ZQ, Zhang LJ, Li J, Liu JQ. Integrated analysis and MicroRNA expression profiling identified seven miRNAs associated with progression of oral squamous cell carcinoma. J Cell Physiol. 2017;232(8):2178-85.
- Zheng W, Liu Z, Zhang W, Hu X. miR-31 functions as an oncogene in cervical cancer. Arch Gynecol Obstet. 2015;292(5):1083-9.
- Chen M, Xu Z, Zhang Y, Zhang X. LINC00958 promotes the malignancy of nasopharyngeal carcinoma by sponging microRNA-625 and thus upregulating NUAK1. Onco Targets Ther. 2019;12:9277-90.
- Nakamura K, Hiyake N, Hamada T, Yokoyama S, Mori K, Yamashiro K, et al. Circulating microRNA Panel as a Potential novel biomarker for oral squamous cell carcinoma diagnosis. Cancers (Basel). 2021;13(3):449.
- Wei Z, Lyu B, Hou D, Liu X. Mir-5100 mediates proliferation, migration and invasion of oral squamous cell carcinoma cells via targeting SCAI. J Invest Surg. 2021;34(8):834-41.
- Morales-Sánchez A, Fuentes-Pananá EM. Human viruses and cancer. Viruses. 2014;6(10):4047-79.
- Vojtechova Z, Tachezy R. The role of miRNAs in virus-mediated oncogenesis. Int J Mol Sci. 2018;19(4):1217.
- Kim S, Park S, Oh JH, Lee SS, Lee Y, Choi J. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression. BMC Oral Health. 2022;22(1):378.
- Fang C, Li Y. Prospective applications of microRNAs in oral cancer. Oncol Lett. 2019;18(4):3974-84.
- Rajan C, Roshan VGD, Khan I, Manasa VG, Himal I, Kattoor J, et al. MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma. Sci Rep. 2021;11(1):7298.
- Ogawa H, Nakashiro K, Tokuzen N, Kuribayashi N, Goda H, Uchida D. MicroRNA‐361‐3p is a potent therapeutic target for oral squamous cell carcinoma. Cancer Sci. 2020;111(5):1645-51.
- Gu Y, Tang S, Wang Z, Cai L, Shen Y, Zhou Y. Identification of key miRNAs and targeted genes involved in the progression of oral squamous cell carcinoma. J Dent Sci. 2022;17(2):666-76.
- Wang J, Lv N, Lu X, Yuan R, Chen Z, Yu J. Diagnostic and therapeutic role of microRNAs in oral cancer. Oncol Rep. 2021;45(1):58-64.
Language: English
Page range: 13 - 18
Submitted on: Dec 12, 2023
Accepted on: Feb 1, 2024
Published online: Apr 11, 2024
Published in print: Mar 1, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2024 Marcin Kolesnik, Anna Polz, Bartlomiej Drop, Malgorzata Polz-Dacewicz, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.